메뉴 건너뛰기




Volumn 51, Issue 17, 2015, Pages 2570-2577

High subcutaneous adipose tissue predicts the prognosis in metastatic castration-resistant prostate cancer patients in post chemotherapy setting

Author keywords

Adipose tissue; Metastatic castration resistant prostate cancer; Overall survival; Skeletal muscle loss

Indexed keywords

ABIRATERONE ACETATE; ENZALUTAMIDE; PREDNISONE; ABIRATERONE; ANDROSTANE DERIVATIVE; ANTINEOPLASTIC AGENT; PHENYLTHIOHYDANTOIN;

EID: 84948586325     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2015.07.042     Document Type: Article
Times cited : (86)

References (36)
  • 3
    • 84940469697 scopus 로고    scopus 로고
    • Management of patients with advanced prostate cancer: Recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015
    • S. Gillessen, A. Omlin, G. Attard, J.S. de Bono, E. Efstathiou, K. Fizazi, and et al. Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015 Ann Oncol 26 2015 1589 1604
    • (2015) Ann Oncol , vol.26 , pp. 1589-1604
    • Gillessen, S.1    Omlin, A.2    Attard, G.3    De Bono, J.S.4    Efstathiou, E.5    Fizazi, K.6
  • 4
    • 84942982616 scopus 로고    scopus 로고
    • Bone-related parameters are the main prognostic factors for overall survival in men with bone metastases from castration-resistant prostate cancer
    • K. Fizazi, C. Massard, M. Smith, M. Rader, J. Brown, P. Milecki, and et al. Bone-related parameters are the main prognostic factors for overall survival in men with bone metastases from castration-resistant prostate cancer Eur Urol 2014 10.1016/j.eururo.2014.10.001
    • (2014) Eur Urol
    • Fizazi, K.1    Massard, C.2    Smith, M.3    Rader, M.4    Brown, J.5    Milecki, P.6
  • 5
    • 74949112755 scopus 로고    scopus 로고
    • Prediction of survival following first-line chemotherapy in men with castration-resistant metastatic prostate cancer
    • A.J. Armstrong, E. Garrett-Mayer, R. de Wit, I. Tannock, and M. Eisenberger Prediction of survival following first-line chemotherapy in men with castration-resistant metastatic prostate cancer Clin Cancer Res 16 2010 203 211
    • (2010) Clin Cancer Res , vol.16 , pp. 203-211
    • Armstrong, A.J.1    Garrett-Mayer, E.2    De Wit, R.3    Tannock, I.4    Eisenberger, M.5
  • 6
    • 84898823273 scopus 로고    scopus 로고
    • Updated prognostic model for predicting overall survival in first-line chemotherapy for patients with metastatic castration-resistant prostate cancer
    • S. Halabi, C.Y. Lin, W.K. Kelly, K.S. Fizazi, J.W. Moul, E.B. Kaplan, and et al. Updated prognostic model for predicting overall survival in first-line chemotherapy for patients with metastatic castration-resistant prostate cancer J Clin Oncol 32 2014 671 677
    • (2014) J Clin Oncol , vol.32 , pp. 671-677
    • Halabi, S.1    Lin, C.Y.2    Kelly, W.K.3    Fizazi, K.S.4    Moul, J.W.5    Kaplan, E.B.6
  • 7
    • 84866595620 scopus 로고    scopus 로고
    • Sarcopenia during androgen-deprivation therapy for prostate cancer
    • M.R. Smith, F. Saad, B. Egerdie, P.R. Sieber, T.L. Tammela, C. Ke, and et al. Sarcopenia during androgen-deprivation therapy for prostate cancer J Clin Oncol 30 2012 3271 3276
    • (2012) J Clin Oncol , vol.30 , pp. 3271-3276
    • Smith, M.R.1    Saad, F.2    Egerdie, B.3    Sieber, P.R.4    Tammela, T.L.5    Ke, C.6
  • 8
    • 0037464510 scopus 로고    scopus 로고
    • Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
    • E.E. Calle, C. Rodriguez, K. Walker-Thurmond, and M.J. Thun Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults N Engl J Med 348 2003 1625 1638
    • (2003) N Engl J Med , vol.348 , pp. 1625-1638
    • Calle, E.E.1    Rodriguez, C.2    Walker-Thurmond, K.3    Thun, M.J.4
  • 9
    • 0034899087 scopus 로고    scopus 로고
    • Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States
    • C. Rodriguez, A.V. Patel, E.E. Calle, E.J. Jacobs, A. Chao, and M.J. Thun Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States Cancer Epidemiol Biomarkers Prev 10 2001 345 353
    • (2001) Cancer Epidemiol Biomarkers Prev , vol.10 , pp. 345-353
    • Rodriguez, C.1    Patel, A.V.2    Calle, E.E.3    Jacobs, E.J.4    Chao, A.5    Thun, M.J.6
  • 10
    • 34648825008 scopus 로고    scopus 로고
    • Inverse correlation between body mass index and clinical outcomes in men with advanced castration-recurrent prostate cancer
    • S. Halabi, S.S. Ou, N.J. Vogelzang, and E.J. Small Inverse correlation between body mass index and clinical outcomes in men with advanced castration-recurrent prostate cancer Cancer 110 2007 1478 1484
    • (2007) Cancer , vol.110 , pp. 1478-1484
    • Halabi, S.1    Ou, S.S.2    Vogelzang, N.J.3    Small, E.J.4
  • 11
    • 45849124963 scopus 로고    scopus 로고
    • Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: A population-based study
    • C.M. Prado, J.R. Lieffers, L.J. McCargar, T. Reiman, M.B. Sawyer, L. Martin, and et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study Lancet Oncol 9 2008 629 635
    • (2008) Lancet Oncol , vol.9 , pp. 629-635
    • Prado, C.M.1    Lieffers, J.R.2    McCargar, L.J.3    Reiman, T.4    Sawyer, M.B.5    Martin, L.6
  • 12
    • 72549086598 scopus 로고    scopus 로고
    • Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer
    • B.H. Tan, L.A. Birdsell, L. Martin, V.E. Baracos, and K.C. Fearon Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer Clin Cancer Res 15 2009 6973 6979
    • (2009) Clin Cancer Res , vol.15 , pp. 6973-6979
    • Tan, B.H.1    Birdsell, L.A.2    Martin, L.3    Baracos, V.E.4    Fearon, K.C.5
  • 13
    • 84904295562 scopus 로고    scopus 로고
    • Sarcopenia is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma treated with immune chemotherapy
    • H. Lanic, J. Kraut-Tauzia, R. Modzelewski, F. Clatot, S. Mareschal, J.M. Picquenot, and et al. Sarcopenia is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma treated with immune chemotherapy Leuk Lymphoma 55 2014 817 823
    • (2014) Leuk Lymphoma , vol.55 , pp. 817-823
    • Lanic, H.1    Kraut-Tauzia, J.2    Modzelewski, R.3    Clatot, F.4    Mareschal, S.5    Picquenot, J.M.6
  • 14
    • 82355190591 scopus 로고    scopus 로고
    • Does obesity influence the prognosis of metastatic renal cell carcinoma in patients treated with vascular endothelial growth factor-targeted therapy?
    • S. Steffens, V. Grunwald, K.I. Ringe, C. Seidel, H. Eggers, M. Schrader, and et al. Does obesity influence the prognosis of metastatic renal cell carcinoma in patients treated with vascular endothelial growth factor-targeted therapy? Oncologist 16 2011 1565 1571
    • (2011) Oncologist , vol.16 , pp. 1565-1571
    • Steffens, S.1    Grunwald, V.2    Ringe, K.I.3    Seidel, C.4    Eggers, H.5    Schrader, M.6
  • 15
    • 77955703763 scopus 로고    scopus 로고
    • Influence of visceral obesity on oncologic outcome in patients with renal cell carcinoma
    • Y. Naya, S. Zenbutsu, K. Araki, K. Nakamura, M. Kobayashi, S. Kamijima, and et al. Influence of visceral obesity on oncologic outcome in patients with renal cell carcinoma Urol Int 85 2010 30 36
    • (2010) Urol Int , vol.85 , pp. 30-36
    • Naya, Y.1    Zenbutsu, S.2    Araki, K.3    Nakamura, K.4    Kobayashi, M.5    Kamijima, S.6
  • 16
    • 79952581004 scopus 로고    scopus 로고
    • Visceral fat area as a new independent predictive factor of survival in patients with metastatic renal cell carcinoma treated with antiangiogenic agents
    • S. Ladoire, F. Bonnetain, M. Gauthier, S. Zanetta, J.M. Petit, S. Guiu, and et al. Visceral fat area as a new independent predictive factor of survival in patients with metastatic renal cell carcinoma treated with antiangiogenic agents Oncologist 16 2011 71 81
    • (2011) Oncologist , vol.16 , pp. 71-81
    • Ladoire, S.1    Bonnetain, F.2    Gauthier, M.3    Zanetta, S.4    Petit, J.M.5    Guiu, S.6
  • 17
    • 84866948935 scopus 로고    scopus 로고
    • Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: Final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study
    • K. Fizazi, H.I. Scher, A. Molina, C.J. Logothetis, K.N. Chi, R.J. Jones, and et al. Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study Lancet Oncol 13 2012 983 992
    • (2012) Lancet Oncol , vol.13 , pp. 983-992
    • Fizazi, K.1    Scher, H.I.2    Molina, A.3    Logothetis, C.J.4    Chi, K.N.5    Jones, R.J.6
  • 18
    • 84921846878 scopus 로고    scopus 로고
    • Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): Final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study
    • C.J. Ryan, M.R. Smith, K. Fizazi, F. Saad, P.F. Mulders, C.N. Sternberg, and et al. Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study Lancet Oncol 16 2015 152 160
    • (2015) Lancet Oncol , vol.16 , pp. 152-160
    • Ryan, C.J.1    Smith, M.R.2    Fizazi, K.3    Saad, F.4    Mulders, P.F.5    Sternberg, C.N.6
  • 19
    • 84856774377 scopus 로고    scopus 로고
    • Clinical and biochemical consequences of CYP17A1 inhibition with abiraterone given with and without exogenous glucocorticoids in castrate men with advanced prostate cancer
    • G. Attard, A.H. Reid, R.J. Auchus, B.A. Hughes, A.M. Cassidy, E. Thompson, and et al. Clinical and biochemical consequences of CYP17A1 inhibition with abiraterone given with and without exogenous glucocorticoids in castrate men with advanced prostate cancer J Clin Endocrinol Metab 97 2012 507 516
    • (2012) J Clin Endocrinol Metab , vol.97 , pp. 507-516
    • Attard, G.1    Reid, A.H.2    Auchus, R.J.3    Hughes, B.A.4    Cassidy, A.M.5    Thompson, E.6
  • 21
    • 84866770294 scopus 로고    scopus 로고
    • Increased survival with enzalutamide in prostate cancer after chemotherapy
    • H.I. Scher, K. Fizazi, F. Saad, M.E. Taplin, C.N. Sternberg, K. Miller, and et al. Increased survival with enzalutamide in prostate cancer after chemotherapy N Engl J Med 367 2012 1187 1197
    • (2012) N Engl J Med , vol.367 , pp. 1187-1197
    • Scher, H.I.1    Fizazi, K.2    Saad, F.3    Taplin, M.E.4    Sternberg, C.N.5    Miller, K.6
  • 22
    • 53649107585 scopus 로고    scopus 로고
    • A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care
    • M. Mourtzakis, C.M. Prado, J.R. Lieffers, T. Reiman, L.J. McCargar, and V.E. Baracos A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care Appl Physiol Nutr Metab 33 2008 997 1006
    • (2008) Appl Physiol Nutr Metab , vol.33 , pp. 997-1006
    • Mourtzakis, M.1    Prado, C.M.2    Lieffers, J.R.3    Reiman, T.4    McCargar, L.J.5    Baracos, V.E.6
  • 23
    • 9244242572 scopus 로고    scopus 로고
    • Total body skeletal muscle and adipose tissue volumes: Estimation from a single abdominal cross-sectional image
    • W. Shen, M. Punyanitya, Z. Wang, D. Gallagher, M.P. St-Onge, J. Albu, and et al. Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image J Appl Physiol 97 2004 2333 2338
    • (2004) J Appl Physiol , vol.97 , pp. 2333-2338
    • Shen, W.1    Punyanitya, M.2    Wang, Z.3    Gallagher, D.4    St-Onge, M.P.5    Albu, J.6
  • 24
    • 84876581806 scopus 로고    scopus 로고
    • Cancer cachexia in the age of obesity: Skeletal muscle depletion is a powerful prognostic factor, independent of body mass index
    • L. Martin, L. Birdsell, N. Macdonald, T. Reiman, M.T. Clandinin, L.J. McCargar, and et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index J Clin Oncol 31 2013 1539 1547
    • (2013) J Clin Oncol , vol.31 , pp. 1539-1547
    • Martin, L.1    Birdsell, L.2    Macdonald, N.3    Reiman, T.4    Clandinin, M.T.5    McCargar, L.J.6
  • 25
    • 0029851283 scopus 로고    scopus 로고
    • A note on quantifying follow-up in studies of failure time
    • M. Schemper, and T.L. Smith A note on quantifying follow-up in studies of failure time Control Clin Trials 17 1996 343 346
    • (1996) Control Clin Trials , vol.17 , pp. 343-346
    • Schemper, M.1    Smith, T.L.2
  • 26
    • 84861543054 scopus 로고    scopus 로고
    • Reporting recommendations for tumor marker prognostic studies (REMARK): Explanation and elaboration
    • D.G. Altman, L.M. McShane, W. Sauerbrei, and S.E. Taube Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration PLoS Med 9 5 2012 e1001216 10.1371 /journal.pmed.1001216
    • (2012) PLoS Med , vol.9 , Issue.5 , pp. e1001216
    • Altman, D.G.1    McShane, L.M.2    Sauerbrei, W.3    Taube, S.E.4
  • 28
  • 30
    • 84902543625 scopus 로고    scopus 로고
    • Prognostic impact of fat tissue loss and cachexia assessed by computed tomography scan in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapy
    • V. Camus, H. Lanic, J. Kraut, R. Modzelewski, F. Clatot, J.M. Pisquenot, and et al. Prognostic impact of fat tissue loss and cachexia assessed by computed tomography scan in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapy Eur J Haematol 93 2014 9 18
    • (2014) Eur J Haematol , vol.93 , pp. 9-18
    • Camus, V.1    Lanic, H.2    Kraut, J.3    Modzelewski, R.4    Clatot, F.5    Pisquenot, J.M.6
  • 31
    • 42149118391 scopus 로고    scopus 로고
    • Regulation of adipose tissue metabolism in cancer cachexia
    • C. Bing, and P. Trayhurn Regulation of adipose tissue metabolism in cancer cachexia Curr Opin Clin Nutr Metab Care 11 2008 201 207
    • (2008) Curr Opin Clin Nutr Metab Care , vol.11 , pp. 201-207
    • Bing, C.1    Trayhurn, P.2
  • 33
    • 54049151993 scopus 로고    scopus 로고
    • Lipolysis - Not inflammation, cell death, or lipogenesis - Is involved in adipose tissue loss in cancer cachexia
    • M. Rydén, T. Agustsson, J. Laurencikiene, T. Britton, E. Sjölin, B. Isaksson, and et al. Lipolysis - not inflammation, cell death, or lipogenesis - is involved in adipose tissue loss in cancer cachexia Cancer 113 2008 1695 1704
    • (2008) Cancer , vol.113 , pp. 1695-1704
    • Rydén, M.1    Agustsson, T.2    Laurencikiene, J.3    Britton, T.4    Sjölin, E.5    Isaksson, B.6
  • 34
    • 84858021383 scopus 로고    scopus 로고
    • Muscle function, physical performance and body composition changes in men with prostate cancer undergoing androgen deprivation therapy
    • T.W. Storer, R. Miciek, and T.G. Travison Muscle function, physical performance and body composition changes in men with prostate cancer undergoing androgen deprivation therapy Asian J Androl 14 2012 204 221
    • (2012) Asian J Androl , vol.14 , pp. 204-221
    • Storer, T.W.1    Miciek, R.2    Travison, T.G.3
  • 35
    • 79851506306 scopus 로고    scopus 로고
    • Increase in visceral and subcutaneous abdominal fat in men with prostate cancer treated with androgen deprivation therapy
    • E.J. Hamilton, E. Gianatti, B.J. Strauss, J. Wentworth, D. Lim-Joon, D. Bolton, and et al. Increase in visceral and subcutaneous abdominal fat in men with prostate cancer treated with androgen deprivation therapy Clin Endocrinol (Oxf) 74 2011 377 383
    • (2011) Clin Endocrinol (Oxf) , vol.74 , pp. 377-383
    • Hamilton, E.J.1    Gianatti, E.2    Strauss, B.J.3    Wentworth, J.4    Lim-Joon, D.5    Bolton, D.6
  • 36
    • 84881110779 scopus 로고    scopus 로고
    • Sarcopenia and change in body composition following maximal androgen suppression with abiraterone in men with castration-resistant prostate cancer
    • C. Pezaro, D. Mukherji, N. Tunariu, A.M. Cassidy, A. Omlin, D. Bianchini, and et al. Sarcopenia and change in body composition following maximal androgen suppression with abiraterone in men with castration-resistant prostate cancer Br J Cancer 109 2013 325 331
    • (2013) Br J Cancer , vol.109 , pp. 325-331
    • Pezaro, C.1    Mukherji, D.2    Tunariu, N.3    Cassidy, A.M.4    Omlin, A.5    Bianchini, D.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.